The MedSurv portal
Who we are
With the MedSurv portal, we provide our customers with an online EDC system for data collection in
- Clinical studies
- Non-interventional studies (NIS)
- Patient registry
- Post-marketing observational studies
- PMCF studies
How we work
We assist our customers all along their way - from their planning of the eCRF to the validation of the system. We also ensure that all project steps are undertaken in a well-structured sequence.
On request, we can offer a full service with reliable and internationally active partners, such as CROs, data managers, statisticians, biometrists, etc.
What makes us who we are
We offer our costumers
- Strong project management
- Fast response times
- Direct and personal support
Our quality results from our certified management system. We are constantly developing ourselves and our user-friendly tools further.
MedSurv is validated according to GAMP5 and certified according to ISO 9001. From these two processes, a well-functioning integrated management system has emerged, which has already successfully passed several audits. Our approach is based on the following guidelines and standards:
- EU Guidelines on GxP, Annex 11 "Computer-Assisted Systems"
- US FDA 21 CFR Part 11 - Electronic records, electronic signature
- FDA Industry Guidelines - Computer-assisted system within the framework of clinical trials and studies
- ICH-GCP Guidelines
- Internal SOPs as well as project-relevant SOPs of our customers
- Tracking of changes according to legal requirements
- Customisable algorithm
- Reliable ratio
- (Serious) adverse events are automatically processed
- Virtual data check
- Current patient and visit status
- Management of the centres
- Additional validation process according to DVP
- Direct communication in the portal
- Daily updates of study data
- Recruitment status...
- Uploading of documents with patient allocation
- Direct collection of questionnaires (QoL)
- Patient diary
"The NIS is unproblematic, well-thought-out and very well processed eletronically. Coordination with MedSurv runs smoothly."
Dr med. Tobias von Kuegelgen / Urologie Wedel, Wedel
"The performance of the MedSurv portal has significantly improved. Now you can work much better and more fluently.“
MICHAEL BAAKE (STUDY COORDINATOR) - ALEXIANER ST. JOSEPH BERLIN-WEISSENSEE GMBH, BERLIN
"In our study, MedSurv GmbH was always an approachable, reliable partner, who responded flexibly to our wishes."
Dr Claudia Neumeister - Dr R. Pfleger GmbH, Bamberg
"We value MedSurv as a reliable and competent partner. Their good accessibility, friendly communication and their dedicated support in particular are always praised by our study staff.“
Dr Simone Nuedling - Med:Unit GmbH, Cologne
"When it comes to project management, the MedSurv team gets full points."
Julia Pache - Biogen GmbH, Ismaning
"We have had very good experience with MedSurv GmbH. The drawing up of a validated databas for our Phase II/III study proceeded rapidly; corrections were made quickly and as desired (even during the ongoing study). Overall, collaboration with MedSurv is very uncomplicated and consistently enjoyable. User support in the centres was also uncomplicated and fast. We can only recommend the MedSurv team."
The Ruxobeat Study Team - Uniklinik RWTH Aachen, Aachen
"Since 2000, I have conducted several scientific studies on the epidemiology of infections together with MedSurv GmbH via the MedSurv portal. Collaboration with Mattes Hamann's team has always worked brilliantly. I particularly appreciate the stability of the web applications, the high security standard in the log-in area for the authorised members (e.g. doctors), as well as the uncomplicated and very timeley implementation of any changes and updates."
Prof. Dr Arne Simon - Clinic for paediatric Oncology and Haematology, University Clinic of Saarland, Homburg/Saar
MedSurv GmbH is still looking for additional staff. Please apply for one of the following vacancies or send in your speculative application.
Please send your application documents to Tina Biehl (email@example.com). We look forward to receiving them.